Loading clinical trials...
Loading clinical trials...
This study will use Continuous Glucose Monitoring to assess differences in glycemic profiles between vildagliptin and glimepiride.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis Pharmaceuticals
NCT07340320 · Type II Diabetes Mellitus
NCT07350694 · Diabetes Type 2, Type II Diabetes Mellitus
NCT07119983 · Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus
NCT06561126 · Type II Diabetes Mellitus, Intermediate Hyperglycemia (IHG)
NCT07362953 · Dyslipidemia Associated With Type II Diabetes Mellitus
Novartis Investigative Site
Mainz
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions